Autistic disorder and viral infections

Journal of NeuroVirology

Volumn 11, Issue 1, 2005, Pages 1-10

  Libbey, Jane E ^a   Sweeten, Thayne L ^a   McMahon, William M ^a   Fujinami, Robert S ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Autism; Immune response; Virus; Virus infection

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; MUMPS VACCINE; RUBELLA VACCINE;

ANTIBODY TITER; ARTHRALGIA; ARTHRITIS; AUTISM; BEHAVIOR DISORDER; BIOASSAY; BORNA DISEASE VIRUS; CENTRAL NERVOUS SYSTEM INFECTION; CHICKENPOX; CONGENITAL INFECTION; CONGENITAL RUBELLA SYNDROME; CYTOMEGALOVIRUS; DISEASE ASSOCIATION; DRUG ERUPTION; DRUG FEVER; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGICAL DATA; HERPES SIMPLEX VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOBLOTTING; INFLUENZA VIRUS; MEASLES VIRUS; NONHUMAN; PAROTITIS; PREGNANCY; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION;

ANIMALS; AUTISTIC DISORDER; HUMANS; MEASLES-MUMPS-RUBELLA VACCINE; VIRUS DISEASES;

EID: 16244384219     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.1080/13550280590900553     Document Type: Review

References (115)

1. Adams JM, Imagawa DT (1962). Measles antibodies in multiple sclerosis. Proc Soc Exp Biol Med 111: 562-566.
2. American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders, 4th (DSM-IV) edition. Washington, DC: American Psychiatric Association.
3. Anlar B, Oktem F, Torok T (1994). Human parvovirus B19 antibodies in infantile autism. J Child Neurol 9: 104-105.
4. Araujo DM, Lapchak PA, Collier B, Quirion R (1989). Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system. Brain Res 498: 257-266.
5. Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, Yuzda E, Rutter M (1995). Autism as a strongly genetic disorder: evidence from a British twin study. Psychol Med 25: 63-77.
6. Barak Y, Kimhi R, Stein D, Gutman J, Weizman A (1999). Autistic subjects with comorbid epilepsy: a possible association with viral infections. Child Psychiatry Hum Dev 29: 245-251.
7. Bartlik BD (1981). Monthly variation in births of autistic children in North Carolina. J Am Med Womens Assoc 36: 363-368.
8. Blattner RJ (1974). The role of viruses in congenital defects. Am J Dis Child 128: 781-786.
9. Chakrabarti S, Fombonne E (2001). Pervasive developmental disorders in preschool children. JAMA 285: 3093-3099.
10. Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, Rose TM, Schultz ER, Bennett JL, Garber RL, Chang M (1995). Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci U S A 92: 7440-7444.
11. Chess S (1971). Autism in children with congenital rubella. J Autism Child Schizophr 1: 33-47.
12. Chess S (1977). Follow-up report on autism in congenital rubella. J Autism Child Schizophr 7: 69-81.
13. Ciaranello AL, Ciaranello RD (1995). The neurobiology of infantile autism. Annu Rev Neurosci 18: 101-128.
14. Coleman M, Gillberg C (1985). The biology of the autistic syndromes. New York: Praeger Publishers.
15. Comi AM, Zimmerman AW, Frye VH, Law PA, Peeden JN (1999). Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol 14: 388-394.
16. Connolly AM, Chez MG, Pestronk A, Arnold ST, Mehta S, Deuel RK (1999). Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders. J Pediatr 134: 607-613.
17. Cook EH Jr (2001). Genetics of autism. Child Adolesc Psychiatr Clin N Am 10: 333-350.
18. Croen LA, Grether JK, Hoogstrate J, Selvin S (2002). The changing prevalence of autism in California. J Autism Dev Disord 32: 207-215.
19. Dales L, Hammer SJ, Smith NJ (2001). Time trends in autism and in MMR immunization coverage in California. JAMA 285: 1183-1185.
20. Dalod M, Salazar-Mather TP, Malmgaard L, Lewis C, Asselin-Paturel C, Briere F, Trinchieri G, Biron CA (2002). Interferon α/β and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J Exp Med 195: 517-528.
21. Dalton P, Deacon R, Blamire A, Pike M, McKinlay I, Stein J, Styles P, Vincent A (2003). Maternal neuronal antibodies associated with autism and a language disorder. Ann Neurol 53: 533-537.
22. DeLong GR, Bean SC, Brown FR III (1981). Acquired reversible autistic syndrome in acute encephalopathic illness in children. Arch Neurol 38: 191-194.
23. Desmond MM, Wilson GS, Verniaud WM, Melnick JL, Rawls WE (1970). The early growth and development of infants with congenital rubella. Adv Teratol 4: 39-63.
24. Deykin EY, MacMahon B (1979). Viral exposure and autism. Am J Epidemiol 109: 628-638.
25. Enbom M (2001). Human herpesvirus 6 in the pathogenesis of multiple sclerosis. APMIS 109: 401-411.
26. Fombonne E (1989). Season of birth and childhood psychosis. Br J Psychiatry 155: 655-661.
27. Fombonne E (1999). The epidemiology of autism: a review. Psychol Med 29: 769-786.
28. Fombonne E, Chakrabarti S (2001). No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics 108: E58.
29. Fotheringham JB (1991). Autism: its primary psychological and neurological deficit. Can J Psychiatry 36: 686-692.
30. Fujinami RS, Libbey JE (1999). Endogenous retroviruses: are they the cause of multiple sclerosis? Trends Microbiol 7: 263-264.
31. Geeraedts F, Wilczak N, van Binnendijk R, De Keyser J (2004). Search for morbillivirus proteins in multiple sclerosis brain tissue. Neuroreport 15: 27-32.
32. Ghaziuddin M, Tsai LY, Eilers L, Ghaziuddin N (1992). Brief report: autism and herpes simplex encephalitis. J Autism Dev Disord 22: 107-113.
33. Ghosh S, Armitage E, Wilson D, Minor PD, Afzal MA (2001). Detection of persistent measles virus infection in Crohn's disease: current status of experimental work. Gut 48: 748-752.
34. Gillberg C (1986). Onset at age 14 of a typical autistic syndrome. A case report of a girl with herpes simplex encephalitis. J Autism Dev Disord 16: 369-375.
35. Gillberg C (1990). Do children with autism have March birthdays? Acta Psychiatr Scand 82: 152-156.
36. Greer MK, Lyons-Crews M, Mauldin LB, Brown FR III (1989). A case study of the cognitive and behavioral deficits of temporal lobe damage in herpes simplex encephalitis. J Autism Dev Disord 19: 317-326.
37. Gregg NM (1941). Congenital cataract following German measles in the mother. Trans Ophthalmol Soc Aust 3: 35-46.
38. Gupta S, Rimland B, Shilling PD (1996). Pentoxifylline: brief review and rationale for its possible use in the treatment of autism. J Child Neurol 11: 501-504.
39. Haase AT, Ventura P, Gibbs CJ Jr, Tourtellotte WW (1981). Measles virus nucleotide sequences: detection by hybridization in situ. Science 212: 672-675.
40. Halsey NA, Hyman SL (2001). Measles-mumps-rubella vaccine and autistic spectrum disorder: report from the New Challenges in Childhood Immunizations Conference convened in Oak Brook, Illinois, June 12-13, 2000. Pediatrics 107: E84.
41. Hanisch U-K, Seto D, Quirion R (1993). Modulation of hippocampal acetylcholine release: a potent central action of interleukin-2. J Neurosci 13: 3368-3374.
42. Hetzler BE, Griffin JL (1981). Infantile autism and the temporal lobe of the brain. J Autism Dev Disord 11: 317-330.
43. Hornig M, Weissenbock H, Horscroft N, Lipkin WI (1999). An infection-based model of neurodevelopmental damage. Proc Natl Acad Sci U S A 96: 12102-12107.
44. Ivarsson SA, Bjerre I, Vegfors P, Ahlfors K (1990). Autism as one of several disabilities in two children with congenital cytomegalovirus infection. Neuropediatrics 21: 102-103.
45. Johnson RT (1982). Viral infections of the developing nervous system. In: Viral infections of the nervous system, 2nd edition. New York: Lippincott-Raven Publishers; pp 203-236.
46. Jorgensen OS, Goldschmidt VV, Vestergaard BF (1982). Herpes simplex virus (HSV) antibodies in child psychiatric patients and normal children. Acta Psychiatr Scand 66: 42-49.
47. Jyonouchi H, Sun S, Le H (2001). Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol 120: 170-179.
48. Kawashima H, Mori T, Kashiwagi Y, Takekuma K, Hoshika A, Wakefield A (2000). Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism. Dig Dis Sci 45: 723-729.
49. Kaye JA, del Mar Melero-Montes M, Jick H (2001). Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ 322: 460-463.
50. Kemper TL, Bauman M (1998). Neuropathology of infantile autism. J Neuropathol Exp Neurol 57: 645-652.
51. Kim IJ, Beck HN, Lein PJ, Higgins D (2002). Interferon gamma induces retrograde dendritic retraction and inhibits synapse formation. J Neurosci 22: 4530-4539.
52. Knobloch H, Pasamanick B (1975). Some etiologic and prognostic factors in early infantile autism and psychosis. Pediatrics 55: 182-191.
53. Konstantareas MM, Hauser P, Lennox C, Homatidis S (1986). Season of birth in infantile autism. Child Psychiatry Hum Dev 17: 53-65.
54. Krause I, He XS, Gershwin ME, Shoenfeld Y (2002). Brief report: immune factors in autism: a critical review. J Autism Dev Disord 32: 337-345.
55. LaFerla FM, Sugarman MC, Lane TE, Leissring MA (2000). Regional hypomyelination and dysplasia in transgenic mice with astrocyte-directed expression of interferon-gamma. J Mol Neurosci 15: 45-59.
56. Landau EC, Cicchetti DV, Klin A, Volkmar FR (1999). Season of birth in autism: a fiction revisited. J Autism Dev Disord 29: 385-393.
57. Legaspi RC, Gatmaitan B, Bailey EJ, Lerner AM (1980). Interferon in biopsy and autopsy specimens of brain. Its presence in herpes simplex virus encephalitis. Arch Neurol 37: 76-79.
58. Lotter V (1966). Epidemiology of autistic conditions in young children. I: Prevalence. Soc Psychiatry 1: 124-137.
59. Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, Olsen J, Melbye M (2002). A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 347: 1477-1482.
60. Makela A, Nuorti JP, Peltola H (2002). Neurologic disorders after measles-mumps-rubella vaccination. Pediatrics 110: 957-963.
61. Markowitz PI (1983). Autism in a child with congenital cytomegalovirus infection. J Autism Dev Disord 13: 249-253.
62. Martin WJ (1995). Stealth virus isolated from an autistic child. J Autism Dev Disord 25: 223-224.
63. Money J, Bobrow NA, Clarke FC (1971). Autism and autoimmune disease: a family study. J Autism Child Schizophr 1: 146-160.
64. Muñoz-Fernández MA, Fresno M (1998). The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog Neurobiol 56: 307-340.
65. Nelson KB (1991). Prenatal and perinatal factors in the etiology of autism. Pediatrics 87: 761-766.
66. Oldstone MBA (1982). Immunopathology of persistent viral infections. Hosp Pract (Off Ed) 17: 61-72.
67. Orange JS, Biron CA (1996). An absolute and restricted requirement for IL-12 in natural killer cell IFN-γ production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J Immunol 156: 1138-1142.
68. Patterson PH (2002). Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness. Curr Opin Neurobiol 12: 115-118.
69. Peltola H, Patja A, Leinikki P, Valle M, Davidkin I, Paunio M (1998). No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet 351: 1327-1328.
70. Pletnikov MV, Rubin SA, Vasudevan K, Moran TH, Carbone KM (1999). Developmental brain injury associated with abnormal play behavior in neonatally Borna disease virus-infected Lewis rats: a model of autism. Behav Brain Res 100: 43-50.
71. Raymond GV, Bauman ML, Kemper TL (1996). Hippocampus in autism: a Golgi analysis. Acta Neuropathol (Berl) 91: 117-119.
72. Ring A, Barak Y, Ticher A, Ashkenazi I, Elizur A, Weizman A (1997). Evidence for an infectious etiology in autism. Pathophysiology 4: 91-96.
73. Risch N, Spiker D, Lotspeich L, Nouri N, Hinds D, Hallmayer J, Kalaydjieva L, McCague P, Dimiceli S, Pitts T, Nguyen L, Yang J, Harper C, Thorpe D, Vermeer S, Young H, Hebert J, Lin A, Ferguson J, Chiotti C, Wiese-Slater S, Rogers T, Salmon B, Nicholas P, Myers RM (1999). A genomic screen of autism: evidence for a multilocus etiology. Am J Hum Genet 65: 493-507.
74. Ritvo ER, Freeman BJ, Scheibel AB, Duong T, Robinson H, Guthrie D, Ritvo A (1986). Lower Purkinje cell counts in the cerebella of four autistic subjects: initial findings of the UCLA-NSAC Autopsy Research Report. Am J Psychiatry 143: 862-866.
75. Rogers T, Kalaydjieva L, Hallmayer J, Petersen PB, Nicholas P, Pingree C, McMahon WM, Spiker D, Lotspeich L, Kraemer H, McCague P, Dimiceli S, Nouri N, Peachy T, Yang J, Hinds D, Risch N, Myers RM (1999). Exclusion of linkage to the HLA region in ninety multiplex sibships with autism. J Autism Dev Disord 29: 195-201.
76. Rosenberger PB (1975). Editorial: infectious disease and the immature brain. N Engl J Med 293: 39-40.
77. Salazar-Mather TP, Hamilton TA, Biron CA (2000). A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. J Clin Invest 105: 985-993.
78. Sargent IL (1993). Maternal and fetal immune responses during pregnancy. Exp Clin Immunogenet 10: 85-102.
79. Sells CJ, Carpenter RL, Ray GG (1975). Sequelae of central-nervous-system enterovirus infections. N Engl J Med 293: 1-4.
80. Shi L, Fatemi SH, Sidwell RW, Patterson PH (2003). Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 23: 297-302.
81. Singh VK, Jensen RL (2003). Elevated levels of measles antibodies in children with autism. Pediatr Neurol 28: 292-294.
82. Singh VK, Lin SX, Newell E, Nelson C (2002). Abnormal measles-mumps-rubella antibodies and GNS autoimmunity in children with autism. J Biomed Sci 9: 359-364.
83. Singh VK, Lin SX, Yang VC (1998). Serological association of measles virus and human herpesvirus-6 with brain autoantibodies in autism. Clin Immunol Immunopathol 89: 105-108.
84. Sola P, Merelli E, Marasca R, Poggi M, Luppi M, Montorsi M, Torelli G (1993). Human herpesvirus 6 and multiple sclerosis: survey of anti-HHV-6 antibodies by immunofluorescence analysis and of viral sequences by polymerase chain reaction. J Neurol Neurosurg Psychiatry 56: 917-919.
85. Steffenburg S, Gillberg C, Hellgren L, Andersson L, Gillberg IC, Jakobsson G, Bohman M (1989). A twin study of autism in Denmark, Finland, Iceland, Norway and Sweden. J Child Psychol Psychiatry 30: 405-416.
86. Stubbs EG (1976). Autistic children exhibit undetectable hemagglutination-inhibition antibody titers despite previous rubella vaccination. J Autism Child Schizophr 6: 269-274.
87. Stubbs EG (1978). Autistic symptoms in a child with congenital cytomegalovirus infection. J Autism Child Schizophr 8: 37-43.
88. Stubbs G (1995). Interferonemia and autism. J Autism Dev Disord 25: 71-73.
89. Sumaya CV, Myers LW, Ellison GW, Ench Y (1985). Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis. Ann Neurol 17: 371-377.
90. Sweeten TL, Bowyer SL, Posey DJ, Halberstadt GM, McDougle CJ (2003a). Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics 112: e420.
91. Sweeten TL, Posey DJ, McDougle CJ (2003b). High blood monocyte counts and neopterin levels in children with autistic disorder. Am J Psychiatry 160: 1691-1693.
92. Sweeten TL, Posev DJ, McDougle CJ (2004a). Autistic disorder in three children with cytomegalovirus infection. J Autism Dev Disord 34: 583-586.
93. Sweeten TL, Posey DJ, Shankar S, McDougle CJ (2004b). High nitric oxide production in autistic disorder: a possible role for interferon-γ. Biol Psychiatry 55: 434-437.
94. Sweeten TL, Posey DJ, Shekhar A, McDougle CJ (2002). The amygdala and related structures in the pathophysiology of autism. Pharmacol Biochem Behav 71: 449-455.
95. Tanoue Y, Oda S, Asano F, Kawashima K (1988). Epidemiology of infantile autism in southern Ibaraki, Japan: differences in prevalence in birth cohorts. J Autism Dev Disord 18: 155-166.
96. Taylor B, Miller E, Farrington CP, Petropoulos MC, Favot-Mayaud I, Li J, Waight PA (1999). Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet 353: 2026-2029.
97. Taylor B, Miller E, Lingam R, Andrews N, Simmons A, Stowe J (2002). Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ 324: 393-396.
98. Thio CL, Thomas DL, Karacki P, Gao X, Marti D, Kaslow RA, Goedert JJ, Hilgartner M, Strathdee SA, Duggal P, O'Brien SJ, Astemborski J, Carrington M (2003). Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol 77: 12083-12087.
99. Ticher A, Ring A, Barak Y, Elizur A, Weizman A (1996). Circannual pattern of autistic births: reanalysis in three ethnic groups. Hum Biol 68: 585-592.
100. Torres AR, Maciulis A, Stubbs EG, Cutler A, Odell D (2002). The transmission disequilibrium test suggests that HLA-DR4 and DR13 are linked to autism spectrum disorder. Hum Immunol 63: 311-316.
101. Treffert DA (1970). Epidemiology of infantile autism. Arch Gen Psychiatry 22: 431-438.
102. Tsunoda I, Fujinami RS (1999). Theiler's murine encephalomyelitis virus. In: Persistent viral infections. Ahmed R, Chen I (eds). Chichester: John Wiley & Sons, pp 517-536.
103. Tuchman RF, Rapin I (1997). Regression in pervasive developmental disorders: seizures and epileptiform electroencephalogram correlates. Pediatrics 99: 560-566.
104. Uhlmann V, Martin CM, Sheils O, Pilkington L, Silva I, Killalea A, Murch SB, Wakefield AJ, O'Leary JJ (2002). Potential viral pathogenic mechanism for new variant inflammatory bowel disease. Mol Pathol 55: 84-90.
105. van Gent T, Heijnen CJ, Treffers PD (1997). Autism and the immune system. J Child Psychol Psychiatry 38: 337-349.
106. Wakefield AJ, Montgomery SM (1999). Autism, viral infection and measles-mumps-rubella vaccination. Isr Med Assoc J 1: 183-187.
107. Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, Berelowitz M, Dhillon AP, Thomson MA, Harvey P, Valentine A, Davies SE, Walker-Smith JA (1998). Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351: 637-641.
108. Wakefield AJ, Pittilo RM, Sim R, Cosby SL, Stephenson JR, Dhillon AP, Pounder RE (1993). Evidence of persistent measles virus infection in Crohn's disease. J Med Virol 39: 345-353.
109. Warren RP, Cole P, Odell JD, Pingree CB, Warren WL, White E, Yonk J, Singh VK (1990). Detection of maternal antibodies in infantile autism. J Am Acad Child Adolesc Psychiatry 29: 873-877.
110. Warren RP, Odell JD, Warren WL, Burger RA, Maciulis A, Daniels WW, Torres AR (1996). Strong association of the third hypervariable region of HLA-DR β1 with autism. J Neuroimmunol 67: 97-102.
111. Weinberg ED (1984). Pregnancy-associated depression of cell-mediated immunity. Rev Infect Dis 6: 814-831.
112. Wong FS, Wen L (2003). The study of HLA class II and autoimmune diabetes. Curr Mol Med 3: 1-15.
113. Wong K (2001). The search for autism's roots. Nature 411: 882-884.
114. Yeargin-Allsopp M, Rice C, Karapurkar T, Doernberg N, Boyle C, Murphy C (2003). Prevalence of autism in a US metropolitan area. JAMA 289: 49-55.
115. Zalcman S, Green-Johnson JM, Murray L, Nance DM, Dyck D, Anisman H, Greenberg AH (1994). Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res 643: 40-49.